Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 10 » default
Diabetes, Metabolic Syndrome and Obesity
ISSN: 1178-7007
- View all (2606)
- Volume 17, 2024 (161)
- Volume 16, 2023 (373)
- Volume 15, 2022 (350)
- Volume 14, 2021 (449)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Archive: Volume 10, 2017
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
Chan WB, Chen JF, Goh SY, Vu TTH, Isip-Tan IT, Mudjanarko SW, Bajpai S, Mabunay MA, Bunnag P
Diabetes, Metabolic Syndrome and Obesity 2017, 10:521-532
Published Date: 15 December 2017
Effects of a proposed physical activity and diet control to manage constipation in middle-aged obese women
Tantawy SA, Kamel DM, Abdelbasset WK, Elgohary HM
Diabetes, Metabolic Syndrome and Obesity 2017, 10:513-519
Published Date: 14 December 2017
Visceral-to-subcutaneous fat ratio as a predictor of the multiple metabolic risk factors for subjects with normal waist circumference in Korea
Oh YH, Moon JH, Kim HJ, Kong MH
Diabetes, Metabolic Syndrome and Obesity 2017, 10:505-511
Published Date: 11 December 2017
Transition from pre-diabetes to diabetes and predictors of risk in Mexican-Americans
Wu SH, McCormick JB, Curran JE, Fisher-Hoch SP
Diabetes, Metabolic Syndrome and Obesity 2017, 10:491-503
Published Date: 6 December 2017
Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
Gruzdeva O, Uchasova E, Dyleva Y, Akbasheva O, Karetnikova V, Shilov A, Barbarash O
Diabetes, Metabolic Syndrome and Obesity 2017, 10:481-489
Published Date: 5 December 2017
Obesity and brain illness: from cognitive and psychological evidences to obesity paradox
Monda V, La Marra M, Perrella R, Caviglia G, Iavarone A, Chieffi S, Messina G, Carotenuto M, Monda M, Messina A
Diabetes, Metabolic Syndrome and Obesity 2017, 10:473-479
Published Date: 21 November 2017
Obesity and morbid obesity associated with higher odds of hypoalbuminemia in adults without liver disease or renal failure
Mosli RH, Mosli HH
Diabetes, Metabolic Syndrome and Obesity 2017, 10:467-472
Published Date: 8 November 2017
Association between metabolic syndrome and sensorineural hearing loss: a cross-sectional study of 11,114 participants
Aghazadeh-Attari J, Mansorian B, Mirza-Aghazadeh-Attari M, Ahmadzadeh J, Mohebbi I
Diabetes, Metabolic Syndrome and Obesity 2017, 10:459-465
Published Date: 6 November 2017
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
Irons BK, Minze MG
Diabetes, Metabolic Syndrome and Obesity 2017, 10:457-458
Published Date: 31 October 2017
Online continuing medical education as a key link for successful noncommunicable disease self-management: the CASALUD™ Model
Gallardo-Rincón H, Saucedo-Martínez R, Mujica-Rosales R, Lee EM, Israel A, Torres-Beltran B, Quijano-González Ú, Atkinson ER, Kuri-Morales P, Tapia-Conyer R
Diabetes, Metabolic Syndrome and Obesity 2017, 10:443-455
Published Date: 16 October 2017
Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan
Bakkar MM, Haddad MF, Gammoh YS
Diabetes, Metabolic Syndrome and Obesity 2017, 10:435-441
Published Date: 11 October 2017
Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives
Fisher VL, Tahrani AA
Diabetes, Metabolic Syndrome and Obesity 2017, 10:419-434
Published Date: 6 October 2017
Weight loss medications in Canada – a new frontier or a repeat of past mistakes?
Wharton S, Lee J, Christensen RAG
Diabetes, Metabolic Syndrome and Obesity 2017, 10:413-417
Published Date: 4 October 2017
Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
Sikirica MV, Martin AA, Wood R, Leith A, Piercy J, Higgins V
Diabetes, Metabolic Syndrome and Obesity 2017, 10:403-412
Published Date: 29 September 2017
Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
Nassour I, Almandoz JP, Adams-Huet B, Kukreja S, Puzziferri N
Diabetes, Metabolic Syndrome and Obesity 2017, 10:393-402
Published Date: 20 September 2017
Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points
Braz MAD, Vieira JN, Gomes FO, Silva PR, Santos OTM, Rocha IMGD, Sousa IMD, Fayh APT
Diabetes, Metabolic Syndrome and Obesity 2017, 10:385-391
Published Date: 12 September 2017
Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P
Diabetes, Metabolic Syndrome and Obesity 2017, 10:375-383
Published Date: 13 September 2017
Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
Le NTD, Dinh Pham L, Quang Vo T
Diabetes, Metabolic Syndrome and Obesity 2017, 10:363-374
Published Date: 29 August 2017
Novel biomarkers for prediabetes, diabetes, and associated complications
Dorcely B, Katz K, Jagannathan R, Chiang SS, Oluwadare B, Goldberg IJ, Bergman M
Diabetes, Metabolic Syndrome and Obesity 2017, 10:345-361
Published Date: 14 August 2017
Diabetes and dyslipidemia: characterizing lipoprotein metabolism
Tomkin GH, Owens D
Diabetes, Metabolic Syndrome and Obesity 2017, 10:333-343
Published Date: 28 July 2017
Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
Yu H, Woo VC
Diabetes, Metabolic Syndrome and Obesity 2017, 10:317-332
Published Date: 21 July 2017
The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
Kumar N, Sullivan S, Thompson CC
Diabetes, Metabolic Syndrome and Obesity 2017, 10:311-316
Published Date: 6 July 2017
Dose-ranging pilot randomized trial of amino acid mixture combined with physical activity promotion for reducing abdominal fat in overweight adults
Sasai H, Ueda K, Tsujimoto T, Kobayashi H, Sanbongi C, Ikegami S, Nakata Y
Diabetes, Metabolic Syndrome and Obesity 2017, 10:297-309
Published Date: 6 July 2017
Prevalence of diabetes and obesity in association with prematurity and growth restriction
Kopec G, Shekhawat PS, Mhanna MJ
Diabetes, Metabolic Syndrome and Obesity 2017, 10:285-295
Published Date: 6 July 2017
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
Lau IT, Lee KF, So WY, Tan K, Yeung VTF
Diabetes, Metabolic Syndrome and Obesity 2017, 10:273-284
Published Date: 30 June 2017
Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region
Bekele S, Yohannes T, Mohammed AE
Diabetes, Metabolic Syndrome and Obesity 2017, 10:265-271
Published Date: 22 June 2017
Diabetes in sub-Saharan Africa – from policy to practice to progress: targeting the existing gaps for future care for diabetes
Pastakia SD, Pekny CR, Manyara SM, Fischer L
Diabetes, Metabolic Syndrome and Obesity 2017, 10:247-263
Published Date: 22 June 2017
Effects of a tailored lifestyle self-management intervention (TALENT) study on weight reduction: a randomized controlled trial
Melchart D, Löw P, Wühr E, Kehl V, Weidenhammer W
Diabetes, Metabolic Syndrome and Obesity 2017, 10:235-245
Published Date: 19 June 2017
Off-label drugs for weight management
Hendricks EJ
Diabetes, Metabolic Syndrome and Obesity 2017, 10:223-234
Published Date: 10 June 2017
Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway
Civantos E, Bosch E, Ramirez E, Zhenyukh O, Egido J, Lorenzo O, Mas S
Diabetes, Metabolic Syndrome and Obesity 2017, 10:207-222
Published Date: 7 June 2017
Personalized multistep cognitive behavioral therapy for obesity
Dalle Grave R, Sartirana M, El Ghoch M, Calugi S
Diabetes, Metabolic Syndrome and Obesity 2017, 10:195-206
Published Date: 1 June 2017
Changes in muscle strength after diet-induced weight reduction in adult men with obesity: a prospective study
Kim B, Tsujimoto T, So R, Zhao X, Oh S, Tanaka K
Diabetes, Metabolic Syndrome and Obesity 2017, 10:187-194
Published Date: 9 May 2017
Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
Mendivil CO, Toloza FJK, Ricardo-Silgado ML, Morales-Álvarez MC, Mantilla-Rivas JO, Pinzón-Cortés JA, Lemus HN
Diabetes, Metabolic Syndrome and Obesity 2017, 10:179-185
Published Date: 8 May 2017
Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis
Suksomboon N, Poolsup N, Darli Ko Ko H
Diabetes, Metabolic Syndrome and Obesity 2017, 10:169-177
Published Date: 2 May 2017
Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
Ahmadieh H, Ghazal N, Azar ST
Diabetes, Metabolic Syndrome and Obesity 2017, 10:161-167
Published Date: 2 May 2017
Hearing thresholds in adult Nigerians with diabetes mellitus: a case–control study
Nwosu JN, Chime EN
Diabetes, Metabolic Syndrome and Obesity 2017, 10:155-160
Published Date: 2 May 2017
Do we need to measure vitamin B12 and magnesium in morbidly obese patients with type 2 diabetes mellitus?
Wåhlén A, Haenni A, Johansson HE
Diabetes, Metabolic Syndrome and Obesity 2017, 10:151-154
Published Date: 2 May 2017
Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
Otieno CFF, Kanu JE, Karari EM, Okech-Helu V, Joshi MD, Mutai K
Diabetes, Metabolic Syndrome and Obesity 2017, 10:141-149
Published Date: 28 April 2017
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
Levin PA, Nguyen H, Wittbrodt ET, Kim SC
Diabetes, Metabolic Syndrome and Obesity 2017, 10:123-139
Published Date: 4 April 2017
Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials
Orme ME, Nguyen H, Lu JY, Thomas SA
Diabetes, Metabolic Syndrome and Obesity 2017, 10:111-122
Published Date: 29 March 2017
Early-life chemical exposures and risk of metabolic syndrome
De Long NE, Holloway AC
Diabetes, Metabolic Syndrome and Obesity 2017, 10:101-109
Published Date: 21 March 2017
The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin
Gerlanc NM, Cai J, Tkacz J, Bolge SC, Brady BL
Diabetes, Metabolic Syndrome and Obesity 2017, 10:89-99
Published Date: 20 March 2017
Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
Courtney H, Nayar R, Rajeswaran C, Jandhyala R
Diabetes, Metabolic Syndrome and Obesity 2017, 10:79-87
Published Date: 13 March 2017
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations
Tatum JA, Meneveau MO, Brayman KL
Diabetes, Metabolic Syndrome and Obesity 2017, 10:73-78
Published Date: 28 February 2017
Clinical utility of metabolic syndrome severity scores: considerations for practitioners
DeBoer MD, Gurka MJ
Diabetes, Metabolic Syndrome and Obesity 2017, 10:65-72
Published Date: 20 February 2017
Association between obesity and heart rate variability indices: an intuition toward cardiac autonomic alteration – a risk of CVD
Yadav RL, Yadav PK, Yadav LK, Agrawal K, Sah SK, Islam MN
Diabetes, Metabolic Syndrome and Obesity 2017, 10:57-64
Published Date: 17 February 2017
Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
Davies MJ, Merton KW, Vijapurkar U, Balis DA, Desai M
Diabetes, Metabolic Syndrome and Obesity 2017, 10:47-55
Published Date: 27 January 2017
Different consecutive training protocols to design an intervention program for overweight youth: a controlled study
Fiorilli G, Iuliano E, Aquino G, Campanella E, Tsopani D, Di Costanzo A, Calcagno G, di Cagno A
Diabetes, Metabolic Syndrome and Obesity 2017, 10:37-45
Published Date: 16 January 2017
The effects of exercise training and caloric restriction on the cardiac oxytocin natriuretic peptide system in the diabetic mouse
Broderick TL, Jankowski M, Gutkowska J
Diabetes, Metabolic Syndrome and Obesity 2017, 10:27-36
Published Date: 11 January 2017
Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity
Karimian S, Stein J, Bauer B, Teupe C
Diabetes, Metabolic Syndrome and Obesity 2017, 10:19-25
Published Date: 7 January 2017
Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation
Lamos EM, Wijesinha MA, Ramhamdani S, Magder LS, Silver KD
Diabetes, Metabolic Syndrome and Obesity 2017, 10:13-17
Published Date: 5 January 2017
Coaching and barriers to weight loss: an integrative review
Muñoz Obino KF, Aguiar Pereira C, Caron-Lienert RS
Diabetes, Metabolic Syndrome and Obesity 2017, 10:1-11
Published Date: 23 December 2016